| License: Creative Commons Attribution 4.0 (2MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-383599
- DOI to cite this document:
- 10.5283/epub.38359
Abstract
Robust anti-tumor immunity requires innate as well as adaptive immune responses. We have shown that plasmacytoid dendritic cells develop killer cell-like activity in melanoma cell cocultures after exposure to the infectious but replication-deficient herpes simplex virus 1 (HSV-1) d 106S. To combine this innate effect with an enhanced adaptive immune response, the gene encoding human MelanA/MART-1 ...
Owner only: item control page